Displaying drugs 1351 - 1375 of 2779 in total
| Name | Weight | Structure | Description | Categories |
|---|---|---|---|---|
| Colchiceine | 385.416 C21H23NO6 |  | Colchiceine is one of several metabolites of the anti-gout medication colchicine. | Alkaloids / Colchicine Derivatives / Tubulin Inhibiting Agent |
| Trifluoperazine | 407.496 C21H24F3N3S |  | A phenothiazine used to treat depression, anxiety, and agitation. | Phenothiazines With Piperazine Structure |
| Moxifloxacin | 401.4314 C21H24FN3O4 |  | A fluoroquinolone antibiotic used to treat various bacterial infections. | Fluoroquinolones |
| Quinupramine | 304.437 C21H24N2 |  | Quinupramine has been approved in France under the brand name Kinupril, as an antidepressant . | Non-Selective Monoamine Reuptake Inhibitors |
| Mirabegron | 396.506 C21H24N4O2S |  | A beta-3 adrenergic agonist used to treat overactive bladder and neurogenic detrusor overactivity. | Drugs for Urinary Frequency and Incontinence |
| Gestrinone | 308.4141 C21H24O2 |  | Endometriosis with or without accompanying sterility. Treatment is limited to a single course of 6 months duration per lifetime [L1699, L1700]. | Antigonadotropins and Similar Agents |
| Bisphenol A diglycidyl ether | 340.4129 C21H24O4 |  | Not Annotated | Carcinogens / Standardized Chemical Allergen |
| Bepotastine | 388.888 C21H25ClN2O3 |  | An ophthalmic H1 antagonist used to treat itchiness associated with allergic conjunctivitis. | Anti-Allergic Agents / Histamine H1 Antagonists |
| Cetirizine | 388.888 C21H25ClN2O3 |  | A selective Histamine-1 antagonist drug used in allergic rhinitis and chronic urticaria. | Piperazine Derivatives |
| Levocetirizine | 388.89 C21H25ClN2O3 |  | An H1-receptor antagonist used to treat symptoms associated with chronic allergic rhinitis and uncomplicated cases of chronic idiopathic urticaria. | Piperazine Derivatives |
| Capivasertib | 428.915 C21H25ClN6O2 |  | A serine/threonine kinase inhibitor used to treat hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer | Proto-Oncogene Proteins c-akt, antagonists & inhibitors |
| Sotagliflozin | 424.94 C21H25ClO5S |  | An orally administered dual SGLT1/2 inhibitor used alongside insulin to improve glycemic control in patients with type 1 diabetes mellitus. | Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors / Sodium-Glucose Transporter 1, antagonists & inhibitors / Sodium-Glucose Transporter 2 Inhibitors |
| Dapagliflozin | 408.873 C21H25ClO6 |  | A sodium-glucose cotransporter 2 inhibitor used in the management of type 2 diabetes mellitus. | Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors / Sodium-Glucose Transport Proteins, antagonists & inhibitors / Sodium-Glucose Transporter 2 Inhibitors |
| Leniolisib | 450.466 C21H25F3N6O2 |  | A phosphoinositide 3-kinase-delta inhibitor that is used to treat activated phosphoinositide 3-kinase delta syndrome. | BCRP/ABCG2 Inhibitors / BCRP/ABCG2 Substrates / Cytochrome P-450 CYP1A2 Inhibitors / Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) / Cytochrome P-450 CYP1A2 Substrates / Cytochrome P-450 CYP2D6 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 CYP3A5 Substrates / Cytochrome P-450 Enzyme Inhibitors / Cytochrome P-450 Substrates / Kinase Inhibitor / OATP1B1/SLCO1B1 Inhibitors / OATP1B3 inhibitors / P-glycoprotein substrates |
| Terbinafine | 291.4299 C21H25N |  | An allylamine antifungal used to treat dermatophyte infections of toenails and fingernails as well as other fungal skin infections. | Antifungals for Systemic Use |
| Quetiapine | 383.507 C21H25N3O2S |  | An atypical antipsychotic agent used for the management of bipolar disorder, schizophrenia, and major depressive disorder. | Diazepines, Oxazepines, Thiazepines and Oxepines |
| Mezlocillin | 539.582 C21H25N5O8S2 |  | Used to treat serious gram–negative infections of the lungs, urinary tract, and skin. | Penicillins With Extended Spectrum |
| Benzatropine | 307.4293 C21H25NO |  | An anticholinergic drug used to treat Parkinson's disease (PD) and extrapyramidal symptoms, except tardive dyskinesia. | Ethers of Tropine or Tropine Derivatives |
| Nalmefene | 339.435 C21H25NO3 |  | An opioid antagonist used to reduce alcohol consumption in adults with alcohol dependence and treat and prevent opioid overdose. | Drugs Used in Alcohol Dependence |
| Perphenazine | 403.969 C21H26ClN3OS |  | A phenothiazine used to treat schizophrenia as well as nausea and vomiting. | Phenothiazines With Piperazine Structure |
| Clemastine | 343.89 C21H26ClNO |  | An antihistamine with sedative and anticholinergic effects used to treat the symptoms of allergic rhinitis. | Aminoalkyl Ethers / Antihistamines for Topical Use |
| Lorpiprazole | 405.469 C21H26F3N5 |  | In 2016, lorpiprazole was classified in the "Chemical structure-related drug-like criteria of global approved drugs" as an antipsychotic and anxiolytic. An antipsychotic is a medication used to treat a state... | Antidepressive Agents / Central Nervous System Depressants / Cytochrome P-450 CYP2D6 Substrates / Cytochrome P-450 CYP3A Substrates / Cytochrome P-450 CYP3A4 Substrates / Cytochrome P-450 Substrates / Drugs that are Mainly Renally Excreted / Serotonin 5-HT2 Receptor Antagonists / Serotonin 5-HT2A Receptor Antagonists / Serotonin 5-HT2C Receptor Antagonists / Serotonin Agents / Serotonin Modulators / Serotonin Receptor Antagonists |
| Florbetaben F-18 | 358.444 C21H26FNO3 |  | A radiopharmaceutical diagnostic agent used during Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients to diagnose the causes of cognitive impairment. | Fluorine Radioisotopes / Radioactive Diagnostic Agent |
| Yohimbine | 354.4427 C21H26N2O3 |  | An alpha-2-adrenergic blocker and sympatholytic found in supplements used to. | Drugs Used in Erectile Dysfunction |
| Samidorphan | 370.449 C21H26N2O4 |  | A novel opioid-system modulator, similar to naltrexone, that functions primarily as a μ-opioid receptor antagonist in vivo and is used primarily in combination with antipsychotics to reduce their metabolic dysfunction-associated adverse effects. | Diazepines, Oxazepines, Thiazepines and Oxepines |
Displaying drugs 1351 - 1375 of 2779 in total